529 related articles for article (PubMed ID: 9872815)
41. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
[TBL] [Abstract][Full Text] [Related]
42. Intrapleural fibrinolytic treatment of multiloculated thoracic empyemas.
Robinson LA; Moulton AL; Fleming WH; Alonso A; Galbraith TA
Ann Thorac Surg; 1994 Apr; 57(4):803-13; discussion 813-4. PubMed ID: 8166523
[TBL] [Abstract][Full Text] [Related]
43. Treatment of complicated pleural fluid collections with image-guided drainage and intracavitary urokinase.
Moulton JS; Benkert RE; Weisiger KH; Chambers JA
Chest; 1995 Nov; 108(5):1252-9. PubMed ID: 7587425
[TBL] [Abstract][Full Text] [Related]
44. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study.
Misthos P; Sepsas E; Konstantinou M; Athanassiadi K; Skottis I; Lioulias A
Eur J Cardiothorac Surg; 2005 Oct; 28(4):599-603. PubMed ID: 16129614
[TBL] [Abstract][Full Text] [Related]
45. Intrapleural alteplase decreases parapneumonic effusion volume in children more than saline irrigation.
Hanson SJ; Havens PL; Simpson PM; Nugent ML; Wells RG
Pediatr Pulmonol; 2015 Dec; 50(12):1328-35. PubMed ID: 25847131
[TBL] [Abstract][Full Text] [Related]
46. [Long-term outcome of intrapleural fibrinolytic therapy via small-bore catheter drainage in the management of complicated parapneumonic effusion and empyema-a case series].
Tasci S; Burghard A; Schäfer H; Rabe C; Ewig S; Lüderitz B
Med Klin (Munich); 2005 Apr; 100(4):181-5. PubMed ID: 15834526
[TBL] [Abstract][Full Text] [Related]
47. [Intrapleural urokinase in the treatment of parapneumonic effusions].
Mencía Bartolomé S; Escudero Rodríguez N; Téllez González C; Moralo García S; Bastida Sánchez E; Torres Tortosa P
An Pediatr (Barc); 2005 May; 62(5):427-32. PubMed ID: 15871824
[TBL] [Abstract][Full Text] [Related]
48. Role of streptokinase in the treatment of acute loculated parapneumonic pleural effusions and empyema.
Bouros D; Schiza S; Panagou P; Drositis J; Siafakas N
Thorax; 1994 Sep; 49(9):852-5. PubMed ID: 7940420
[TBL] [Abstract][Full Text] [Related]
49. Pharmacotherapy in complicated parapneumonic pleural effusions and thoracic empyema.
Schiza SE; Antoniou KM; Economidou FN; Siafakas NM
Pulm Pharmacol Ther; 2005; 18(6):381-9. PubMed ID: 15998594
[TBL] [Abstract][Full Text] [Related]
50. Intrapleural fibrinolytic therapy in complicated parapneumonic effusion and empyema: present status.
Barthwal MS
Indian J Chest Dis Allied Sci; 2008; 50(3):277-82. PubMed ID: 18630794
[TBL] [Abstract][Full Text] [Related]
51. Intrapleural streptokinase for the treatment of complicated parapneumonic effusion and empyema in 2 newborns.
Yigit AK; Yilmaz Y; Erdeve O; Gokce IK; Oguz SS; Uras N; Dilmen U
J Pediatr Surg; 2012 Oct; 47(10):e41-4. PubMed ID: 23084230
[TBL] [Abstract][Full Text] [Related]
52. Recombinant tissue plasminogen activator in the treatment of pleural infections in adults.
Froudarakis ME; Kouliatsis G; Steiropoulos P; Anevlavis S; Pataka A; Popidou M; Mikroulis D; Pneumatikos I; Bouros D
Respir Med; 2008 Dec; 102(12):1694-700. PubMed ID: 18824340
[TBL] [Abstract][Full Text] [Related]
53. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions.
Chin NK; Lim TK
Chest; 1997 Feb; 111(2):275-9. PubMed ID: 9041968
[TBL] [Abstract][Full Text] [Related]
54. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
Israel EN; Blackmer AB
Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
[TBL] [Abstract][Full Text] [Related]
55. Intrapleural fibrinolysis in the management of empyemas and haemothoraces. Our experience.
Basile A; Boullosa-Seoane E; Dominguez Viguera L; Certo A; Mundo E; Garcia-Medina J; Casal-Rivas M
Radiol Med; 2003; 105(1-2):12-6. PubMed ID: 12700540
[TBL] [Abstract][Full Text] [Related]
56. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis.
Tokuda Y; Matsushima D; Stein GH; Miyagi S
Chest; 2006 Mar; 129(3):783-90. PubMed ID: 16537882
[TBL] [Abstract][Full Text] [Related]
57. Parapneumonic effusions and empyema.
Light RW
Clin Chest Med; 1985 Mar; 6(1):55-62. PubMed ID: 3847302
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of intrapleural tissue-type plasminogen activator in the treatment of loculated parapneumonic effusions.
Zuckerman DA; Reed MF; Howington JA; Moulton JS
J Vasc Interv Radiol; 2009 Aug; 20(8):1066-9. PubMed ID: 19560940
[TBL] [Abstract][Full Text] [Related]
59. Treatment of complicated pleural effusion with intracavitary urokinase in children.
de Benedictis FM; De Giorgi G; Niccoli A; Troiani S; Rizzo F; Lemmi A
Pediatr Pulmonol; 2000 Jun; 29(6):438-42. PubMed ID: 10821725
[TBL] [Abstract][Full Text] [Related]
60. Phase 1 trial of intrapleural LTI-01; single chain urokinase in complicated parapneumonic effusions or empyema.
Beckert L; Brockway B; Simpson G; Southcott AM; Lee YCG; Rahman N; Light RW; Shoemaker S; Gillies J; Komissarov AA; Florova G; Ochran T; Bradley W; Ndetan H; Singh KP; Sarva K; Idell S
JCI Insight; 2019 Apr; 5(10):. PubMed ID: 30998508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
